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Abstract
The early recognition and management of sepsis remain the
greatest challenges in the field of critical care medicine.
Endothelial injury is one of the hallmarks of sepsis, leading to
capillary leak, microcirculatory dysfunction, organ failure, and
eventual death in many critically ill patients. The angiogenic growth
factors, angiopoietin (angpt)-1 and angpt-2, act upon the Tie-2
receptor in opposing roles. Angpt-2 has been found in abundance
in septic patients when compared with healthy controls. In the
study by Kümpers and colleagues in the previous issue of Critical
Care, angpt-2 levels correlated with markers of tissue hypoxia,
disease severity, and mortality in septic adults. However, the
temporal kinetics of the angiopoietins were not assessed. It
remains to be seen whether angpt-2 levels will function solely as
an early marker of sepsis or whether the manipulation of the
angpt/Tie-2 system will become a rational therapeutic target for the
management of sepsis.
In the previous issue of Critical Care, Kümpers and
colleagues [1] demonstrated a direct correlation between
increased peripheral blood levels of the vascular growth
factor, angiopoietin (angpt)-2, and mortality in 43 critically ill
adults with sepsis. Endothelial injury is one of the main
hallmarks of sepsis, leading to capillary leak, microcirculatory
dysfunction, organ failure, and eventual death in many
critically ill patients [2]. Angpt-1 and angpt-2 are two of the
best-characterized members of a family of endothelial-derived
vascular growth factors necessary for both normal and
pathologic angiogenesis and vasculogenesis. Both angpt-1
and angpt-2 appear to bind to the tyrosine kinase receptor,
Tie-2, found primarily on the luminal surface of endothelial
cells [3]. Recent studies have also shown that the Tie-2
receptor may be found on certain populations of peripheral
blood monocytes [4], although the function and role of the
Tie-2 receptor in the host innate immune response remain
relatively unexplored. Angpt-1 and angpt-2 appear to have
directly opposing roles during health and disease states.
Angpt-1 is a Tie-2 agonist and promotes endothelial stabili-
zation and quiescence, whereas angpt-2 is a Tie-2 antagonist
and promotes endothelial activation, destabilization, and
inflammation [3]. As such, the relative balance between
angpt-2 and angpt-1 at the Tie-2 receptor may be more
relevant to the pathobiology of sepsis than the absolute levels
of the individual growth factors [5,6].
Several studies have demonstrated increased peripheral
blood levels of angpt-2 in critically ill patients with sepsis
[5,7-9], multiple trauma [10,11], acute lung injury (ALI)
[7,12,13], and cardiopulmonary bypass [6] when compared
with healthy controls. More importantly, increased angpt-2
levels appear to be associated with adverse outcomes
[5,6,9-12]. For example, the study of Kümpers and
colleagues [1] showed that increased peripheral blood
angpt-2 levels correlated with surrogate markers of tissue
hypoxia, disease severity, and mortality in 43 critically ill
adults with sepsis. Also of note, consistent with the opposing
roles of angpt-2 and angpt-1 on the Tie-2 receptor, peripheral
blood levels of angpt-1 were significantly lower in the patients
with sepsis compared with healthy controls. Unfortunately, in
the study of Kümpers and colleagues, similar to the
aforementioned studies, the temporal kinetics of angpt-1 and
angpt-2 were not assessed as blood samples were collected
upon the first day of admission to the intensive care unit only.
Angpt-2 is stored in the Weibel-Palade bodies within
endothelial cells [14] in a more or less prepackaged form. It is
therefore not surprising that angpt-2 levels are increased
early in response to endothelial activation or injury. Whether
angpt-2 levels remain increased in critically ill patients with
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sepsis has not been directly addressed and is a question for
future investigation. It is certainly tempting to speculate that
peripheral blood angpt-2 levels would be an ideal biomarker
of early endothelial activation and injury. Similarly, whether
angpt-1 levels remain decreased in critically ill patients who
eventually succumb to their illness is an interesting question.
Angpt-1 may be a biomarker of endothelial recovery;
however, given its purported anti-inflammatory role, angpt-1
would appear to be an attractive therapeutic target as well.
To this end, several studies have suggested that manipulating
the ratio of angpt-2 to angpt-1 by augmenting angpt-1 levels
may represent an ideal therapeutic strategy for patients with
sepsis and ALI [15].
Important translational laboratory studies are necessary to
show that increased angpt-2 levels in critically ill patients are
more than just an epiphenomenon. The role of angpt-2 in the
pathobiology of sepsis and ALI needs to be further
elucidated by using in vitro cell-based studies and animal
models of critical illness. Similarly, the presence of the Tie-2
receptor on certain subpopulations of peripheral blood
monocytes [4] suggests a larger role for angpt-2 in the host
innate immune response. Finally, manipulation of the
angpt/Tie-2 system may be a rational therapeutic strategy for
the management of critically ill patients with sepsis and ALI.
All of these questions remain an active focus in several
laboratories, including our own.
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